zurück

EU-HTA

#

JCA update available

04.02.2026
We provide you with the latest regulatory update from the EMA, announced last week ...
#

Fallacy 4: PICO is driven by payer archetype – really?

03.02.2026
PICO scoping is quite complex, and 27 member states (plus 3 EEA countries) are a lot ...
#

Our HTA insights Q4 2025 are now available 🌍

30.01.2026
Together with our local partners and experts, we’ve analyzed HTA decisions from 13 countries across Europe and Canada from October to December 2025 ...
#

Tool News PART 10: The European HTA landscape in one database

28.01.2026
Oncology products and Advanced Therapy Medicinal Products (ATMPs) are among the first drugs subjected to EU HTA ...
#

Fallacy 3: Impact of JCA is limited to Europe – really?

20.01.2026
JCA is an assessment of clinical evidence on behalf of all 27 member states of the European Union, and 3 EEA countries ...
#

Part 2: insights into our projects

15.01.2026
One strategy does not fit all. How our network helped a global client with country-specific expertise ...
#

Fallacy 2: Global Value Dossier can be used as basis for JCA – really?

07.01.2026
Some people do argue that the Global Value Dossier (GVD) can be used as basis for JCA.
#

JCA updates

12.12.2025
With the latest regulatory update from EMA announced this week we expect the first JCA Report to be published not before May 2026. ...
#

Network support in complex pricing challenges in Europe

11.12.2025
How our network supported a client in navigating complex pricing challenges in Europe ...
#

From gap analysis to integrated evidence-generation plan

10.12.2025
A gap analysis, based on the consolidated assumed assessment scope (part 8 of our Tool News), helps identyfing current gaps in your evidence ...
#

JCA is optional – really?

25.11.2025
Some people think that the submission of a #JCA is optional and you can decide whether to provide it or not...
#

Why prepare a consolidated assumed assessment scope?

18.11.2025
  The European Commission will share the consolidated assessment scope with your first request. Your scope serves a triple purpose ...

 

Ansprechpartner

Dr. Thomas Ecker

Dr. Thomas Ecker
Tel. +49 (40) 41 33 081-10

 

Janine Leismann

Janine Leismann
Tel. +49 (40) 41 33 081-26